胰腺神经内分泌肿瘤中端粒替代延长表型的CT影像基因组学特征
本研究回顾性纳入121例经手术切除的胰腺神经内分泌肿瘤患者的术前多期CT,由两名放射科医师盲法评估肿瘤大小、形态、囊变或坏死、钙化、血管侵犯、胰管扩张及肝转移等特征。单因素分析显示分叶或不规则形态、肿瘤坏死、血管侵犯、胰管扩张和肝转移与端粒替代延长表型显著相关;多因素分析显示胰管扩张、肝转移与肿瘤大小≥3 cm的组合是端粒替代延长表型的强预测因素(比值比=20.3;95%CI=2.3-176.3;AUC=0.58;p=0.006)。结论认为若干术前CT特征与端粒替代延长表型相关,且瘤内钙化和转移可独立于端粒替代延长状态预测不良生存。
要点
- 分叶或不规则形态、坏死、血管侵犯、胰管扩张和肝转移与端粒替代延长表型相关。
- 胰管扩张、肝转移与肿瘤大小≥3 cm组合预测端粒替代延长表型的比值比=20.3(95%CI=2.3-176.3)。
- 瘤内钙化和转移可独立于端粒替代延长状态预测不良生存。
核心结论
- 若干术前CT特征与胰腺神经内分泌肿瘤的端粒替代延长表型相关,该表型已知预测不良预后;瘤内钙化和转移可独立于端粒替代延长状态预测不良生存。
研究设计与样本
- 回顾性研究,纳入121例经手术切除的胰腺神经内分泌肿瘤患者的术前多期CT检查,由两名放射科医师独立盲法评估肿瘤特征,以Fisher精确检验或t检验进行单因素分析,以多元逻辑回归进行多因素分析。
关键影像表现/征象
- 分叶或不规则肿瘤形态与端粒替代延长表型显著相关(p=0.001)。
- 肿瘤坏死与端粒替代延长表型显著相关(p=0.002)。
- 血管侵犯与端粒替代延长表型显著相关(p<0.001)。
- 胰管扩张与端粒替代延长表型显著相关(p<0.001)。
- 肝转移与端粒替代延长表型显著相关(p<0.001)。
诊断标准与关键数值
- 多因素分析中,胰管扩张、肝转移与肿瘤大小≥3 cm的组合预测端粒替代延长表型:比值比=20.3;95%CI=2.3-176.3;AUC=0.58;p=0.006。
临床应用与阅片要点
- 阅片时可关注分叶或不规则形态、肿瘤坏死、血管侵犯、胰管扩张和肝转移等与端粒替代延长表型相关的CT特征。
- 胰管扩张、肝转移与肿瘤大小≥3 cm的组合对端粒替代延长表型有强预测价值(比值比=20.3),但AUC=0.58提示区分能力有限。
- 瘤内钙化和转移可独立于端粒替代延长状态预测不良生存,报告时可予以描述。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of this study was to identify imaging characteristics in patients with known pancreatic neuroendocrine tumors (PanNETs) that predict the alternative lengthening of telomeres (ALT) phenotype by blinded retrospective review of preoperative multiphasic CT scans.
MATERIALS AND METHODS: For this retrospective study of 121 preoperative CT examinations of patients with resected PanNETs, two radiologists independently reviewed the CT examinations for tumor characteristics including size, shape, cystic or necrotic elements, calcifications, invasion of adjacent organs and vessels, biliary duct dilatation, pancreatic duct dilatation, and hepatic metastases. Univariate analysis of association of CT characteristics with ALT phenotype was performed with Fisher exact tests or t tests, and multivariate analysis was assessed by multiple logistic regression.
RESULTS: Univariate analysis showed that the following CT features were significantly associated with the ALT phenotype: lobulated or irregular tumor shape (p = 0.001), tumor necrosis (p = 0.002), vascular invasion (p < 0.001), pancreatic duct dilatation (p < 0.001), and hepatic metastasis (p < 0.001). Multivariate analysis found that the combination of pancreatic duct dilatation, hepatic metastasis, and size of tumor ≥ 3 cm was a strong predictor of ALT phenotype (odds ratio = 20.3; 95% CI = 2.3-176.3; AUC = 0.58; p = 0.006).
CONCLUSION: This study showed that several preoperative CT features of PanNETs are associated with the ALT phenotype, which is known to predict poor prognosis. Additionally, CT findings of intratumoral calcifications and metastases predicted poor survival independent of the ALT status.
引用
- McGovern JM, Singhi AD, Borhani AA, et al. CT Radiogenomic Characterization of the Alternative Lengthening of Telomeres Phenotype in Pancreatic Neuroendocrine Tumors. AJR Am J Roentgenol. 2018. PMID: 30160983. doi:10.2214/AJR.17.19490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。